Eventide Healthcare & Life Sciences Fund

U.S. News evaluated 34 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Eventide Funds funds

See full Health rankings

See more fund rankings

Performance

The fund has returned 73.40 percent over the past year.

Trailing Returns Updated 02.28.2014
Year to date 17.8%
1 Year 73.4%
3 Years (Annualized) N/A
5 Years (Annualized) N/A
10 Years (Annualized) N/A

See more ETCHX performance

Summary

The investment seeks to provide long-term capital appreciation. Under normal market conditions, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It is non-diversified.

Fees

Fees are Low compared to funds in the same category.
Eventide Healthcare & Life Sciences Fund has an expense ratio of 2.43 percent.

See more ETCHX fees

Risk

Risk is N/A compared to funds in the same category according to Morningstar.

See more ETCHX risk